Linda Burkly
Chief Tech/Sci/R&D Officer at EDITAS MEDICINE, INC.
Net worth: 630 863 $ as of 2024-03-30
Profile
Linda C.
Burkly is currently the Chief Scientific Officer & Executive VP at Editas Medicine, Inc. Prior to her current position, she worked at Biogen, Inc. as the Vice President & Senior Distinguished Investigator from 2014 to 2022.
Burkly received her undergraduate degree from Fairfield University and her doctorate from Tufts University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
EDITAS MEDICINE, INC.
0.10% | 2024-03-01 | 85,022 ( 0.10% ) | 630 863 $ | 2024-03-30 |
Linda Burkly active positions
| Companies | Position | Start |
|---|---|---|
| EDITAS MEDICINE, INC. | Chief Tech/Sci/R&D Officer | 2023-07-23 |
Former positions of Linda Burkly
| Companies | Position | End |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 2021-12-31 |
Training of Linda Burkly
| Fairfield University | Undergraduate Degree |
| Tufts University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| BIOGEN INC. | Health Technology |
| EDITAS MEDICINE, INC. | Health Technology |
- Stock Market
- Insiders
- Linda Burkly
